Federal Register Notice: FDA is announcing that a proposed collection of information entitled, “Adverse Experience Reporting for Licensed Biological Products; and General Records” has been submitted to the Office of Management and Budget for review and clearance under the Paperwork Reduction Act of 1995. To view this notice, click here.
